Diabetes Metab J.  2011 Feb;35(1):86-87. 10.4093/dmj.2011.35.1.86.

Letter: A Retrospective Study on the Efficacy of a Ten-Milligram Dosage of Atorvastatin for Treatment of Hypercholesterolemia in Type 2 Diabetes Mellitus Patients (Korean Diabetes J 2010;34:359-67)

• Rhee EJ

• KMID: 2281497
• DOI: http://doi.org/10.4093/dmj.2011.35.1.86

Abstract

No abstract available.

MeSH Terms

Diabetes Mellitus, Type 2
Heptanoic Acids
Humans
Hypercholesterolemia
Pyrroles
Retrospective Studies
Atorvastatin Calcium
Heptanoic Acids
Pyrroles

Reference

1. Dunn FL. Management of dyslipidemia in people with type 2 diabetes mellitus. Rev Endocr Metab Disord. 2010. 11:41–51.

2. American Diabetes Association. Standards of medical care in diabetes--2009. Diabetes Care. 2009. 32:Suppl 1. S13–S61.

3. Kim DK, Lee SR, Kim MS, Bae SH, Hwang JY, Kim JM, Suh SH, Lee HJ, Park MK, Kim DK. A retrospective study on the efficacy of a ten-milligram dosage of atorvastatin for treatment of hypercholesterolemia in type 2 diabetes mellitus patients. Korean Diabetes J. 2010. 34:359–367.

4. Simpson RJ Jr, Mendys P. The effects of adherence and persistence on clinical outcomes in patients treated with statins: a systematic review. J Clin Lipidol. 2010. 4:462–471.

5. Ho PM, Rumsfeld JS, Masoudi FA, McClure DL, Plomondon ME, Steiner JF, Magid DJ. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006. 166:1836–1841.

6. Liao JK. Safety and efficacy of statins in Asians. Am J Cardiol. 2007. 99:410–414.

7. Morales D, Chung N, Zhu JR, Sangwatanaroj S, Yin WH, Lee K, Davies MJ, Shah A, Loeys T, Bilheimer D. Efficacy and safety of simvastatin in Asian and non-Asian coronary heart disease patients: a comparison of the GOALLS and STATT studies. Curr Med Res Opin. 2004. 20:1235–1243.

8. Arnaboldi L, Corsini A. Do structural differences in statins correlate with clinical efficacy? Curr Opin Lipidol. 2010. 21:298–304.

9. Goldberg RB, Guyton JR, Mazzone T, Weinstock RS, Polis AB, Tipping D, Tomassini JE, Tershakovec AM. Relationships between metabolic syndrome and other baseline factors and the efficacy of ezetimibe/simvastatin and atorvastatin in patients with type 2 diabetes and hypercholesterolemia. Diabetes Care. 2010. 33:1021–1024.

10. Shear CL, Franklin FA, Stinnett S, Hurley DP, Bradford RH, Chremos AN, Nash DT, Langendorfer A. Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. Effect of patient characteristics on lovastatin-induced changes in plasma concentrations of lipids and lipoproteins. Circulation. 1992. 85:1293–1303.

11. Simon JA, Lin F, Hulley SB, Blanche PJ, Waters D, Shiboski S, Rotter JI, Nickerson DA, Yang H, Saad M, Krauss RM. Phenotypic predictors of response to simvastatin therapy among African-Americans and Caucasians: the Cholesterol and Pharmacogenetics (CAP) Study. Am J Cardiol. 2006. 97:843–850.